Hyperglycemia is a hallmark of diabetes. Adverse pathological effects of hyperglycemia include the increased posttranslational modification of cellular proteins at serine and threonine residues by the sugar N- acetylglucosamine, in a process termed O-GlcNAcylation. We found that the transcription factor nuclear factor- kappaB (NF-?B) subunit, c-Rel, is a target for this pathologic O-GlcNAcylation. Our preliminary data shows that c-Rel is O-GlcNAcylated at serine residue 350 in T lymphocytes. c-Rel is the major regulator of T cell function and T regulatory (T reg) cell development that controls autoimmunity and immunosuppression, respectively. We found that c-Rel O-GlcNAcylation increases its transcriptional activity and the expression of pro- autoimmune cytokines interleukin-2 (IL-2) and interferon gamma (IFNG), and decreases the expression of the transcription factor, forkhead box P3 (FOXP3) in T cells. Based on this, we hypothesize that O-GlcNAcylation of c-Rel serves as a key regulatory switch with dual roles in controlling transcription in T cells and T reg cells promoting autoimmunity in type 1 diabetes. Here, we propose to study the role of c-Rel O-GlcNAcylation in (1) the transcriptional regulation of proautoimmune cytokines and T cell function (2) regulation of FOXP3 transcription, T reg cell development and immunosuppression and (3) T cell-mediated autoimmunity using non- GlcNAcylatable c-Rel expressing non obese diabetic (NOD) mouse model. This study explores the emerging area of immunometabolism. It reveals c-Rel O-GlcNAcylation as a novel glucose metabolism-dependent molecular mechanism that regulates autoimmunity. Inhibition of total NF-kappaB elicits broad side effects and despite decades of research, drugs based on molecular targets to treat type 1 diabetes have remained elusive. Therefore, understanding unique post-translational modifications such as O-GlcNAcylation, that NF-kappaB undergoes, could prove a potential therapeutic target and lead to develop drugs with higher specificity. Moreover, this study serves as the basis to explore the role of c-Rel O-GlcNAcylation in other autoimmune diseases such as celiac disease, lupus and arthritis, where c-Rel function has been implicated.

Public Health Relevance

Type 1 diabetes or autoimmune diabetes is a chronic, lifelong disease with over 15000 children diagnosed every year and more than 370 million people affected worldwide. The proposed project will reveal a novel molecular mechanism promoting self-reactivity of immune cells (autoimmunity) in type 1 diabetes. This study will generate two new publicly available mouse models of this disease. It will also lay the foundation to develop potential therapeutic reagents to treat type 1 diabetes and ameliorate its secondary complications such as renal failure, blindness, heart problems and nerve damage.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Research Project (R01)
Project #
Application #
Study Section
Cellular Signaling and Regulatory Systems Study Section (CSRS)
Program Officer
Rice, Jeffrey S
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Case Western Reserve University
Schools of Medicine
United States
Zip Code
Asthana, Abhishek; Ramakrishnan, Parameswaran; Vicioso, Yorleny et al. (2018) Hexosamine Biosynthetic Pathway Inhibition Leads to AML Cell Differentiation and Cell Death. Mol Cancer Ther 17:2226-2237
de Jesus, Tristan; Shukla, Sudhanshu; Ramakrishnan, Parameswaran (2018) Too sweet to resist: Control of immune cell function by O-GlcNAcylation. Cell Immunol 333:85-92
Tomalka, Jeffrey A; de Jesus, Tristan J; Ramakrishnan, Parameswaran (2017) Sam68 is a regulator of Toll-like receptor signaling. Cell Mol Immunol 14:107-117
Farabaugh, Kenneth T; Majumder, Mithu; Guan, Bo-Jhih et al. (2017) Protein Kinase R Mediates the Inflammatory Response Induced by Hyperosmotic Stress. Mol Cell Biol 37:
Ramakrishnan, Parameswaran; Yui, Mary A; Tomalka, Jeffrey A et al. (2016) Deficiency of Nuclear Factor-?B c-Rel Accelerates the Development of Autoimmune Diabetes in NOD Mice. Diabetes 65:2367-79